Kikam, Adeline – Trademark Portfolio
Entity Type: 01
Kikam, Adeline holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 3 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BROWN SKIN DERM and SKINCLUSIVE DERMATOLOGY & COSMETIC SURGERY. The owner is based in edinburg, TX.
2803 Javalina Ave, unit 2
edinburg, TX 78542
Showing of trademarks Trademarks
Trademark Classifications
Kikam, Adeline's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Kikam, Adeline have?
Kikam, Adeline has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.
What trademark classes does Kikam, Adeline file in?
Kikam, Adeline files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Kikam, Adeline's most well-known trademarks?
Kikam, Adeline's registered trademark portfolio includes well-known marks such as BROWN SKIN DERM and SKINCLUSIVE DERMATOLOGY & COSMETIC SURGERY. These are among 2 currently registered trademarks in the portfolio.
What is Kikam, Adeline's trademark registration success rate?
Kikam, Adeline has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.